Dupixent (dupilumab)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Dupixent (dupilumab), covering 2025-12-02 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Biosimilarity of GLR1044 Injection and Dupilumab Injection (Dupixent®) in Healthy Adult Male Subjects [Phase 1]